Bridging the innovation gap: Scalable cell therapies, adapti...

Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.

ESMO 2025 in review: A new era in oncology, from AI to next-...

ESMO 2025 reflected a field in the midst of rapid evolution – one that is increasingly defined by personalisation and data-driven decision-making.

Exploring the unconventional to provide hope: Dr Jason Willi...